Opinion
Published on 31 May 2022
Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.921307
- 1,312 views
- 1 citation
Type at least 3 characters
532 articles
Articles
Original Research
Published on 31 May 2022
Age-Related Increase of Collagen/Fibrin Deposition and High PAI-1 Production in Human Nasal Polyps
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.845324
- 2,487 views
- 1 citation
Original Research
Published on 31 May 2022
Supplementation With Spirulina platensis Improves Tracheal Reactivity in Wistar Rats by Modulating Inflammation and Oxidative Stress
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.826649
- 1,624 views
- 2 citations
Original Research
Published on 26 May 2022
S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.892307
- 1,287 views
- 5 citations
Original Research
Published on 20 May 2022
TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.911945
- 1,859 views
- 2 citations
Original Research
Published on 20 May 2022
The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.860492
- 2,734 views
- 6 citations
Original Research
Published on 20 May 2022
Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.903378
- 8,704 views
- 4 citations
Original Research
Published on 19 May 2022
NOX4 Mediates Epithelial Cell Death in Hyperoxic Acute Lung Injury Through Mitochondrial Reactive Oxygen Species
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.880878
- 2,200 views
- 4 citations
Editorial
Published on 19 May 2022
Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.910212
- 989 views
Review
Published on 17 May 2022
Emerging Roles of Non-Coding RNAs in Childhood Asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.856104
- 3,351 views
- 5 citations
Original Research
Published on 12 May 2022
Dihydroquercetin Attenuates Silica-Induced Pulmonary Fibrosis by Inhibiting Ferroptosis Signaling Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.845600
- 6,753 views
- 17 citations
Review
Published on 11 May 2022
Unravelling the Therapeutic Potential of Botanicals Against Chronic Obstructive Pulmonary Disease (COPD): Molecular Insights and Future Perspectives
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.824132
- 2,669 views
- 6 citations
Original Research
Published on 11 May 2022
Construction of Severe Eosinophilic Asthma Related Competing Endogenous RNA Network by Weighted Gene Co-Expression Network Analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.852536
- 3,390 views
- 3 citations
Original Research
Published on 11 May 2022
Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.860944
- 2,464 views
- 5 citations
Original Research
Published on 09 May 2022
Vincristine Promotes Transdifferentiation of Fibroblasts Into Myofibroblasts via P38 and ERK Signal Pathways
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.901000
- 1,845 views
- 3 citations
Original Research
Published on 05 May 2022
Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.898422
- 4,473 views